The current NAUT market cap is 158.95M. The company's latest EPS is USD -0.5048 and P/E is -2.36.
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -576k | -50.5M | -63.62M | -76.15M |
Net Income | -523k | -50.32M | -57.92M | -63.68M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 150.86M | 398.45M | 350.05M | 305.57M |
Total Liabilities | 5.62M | 34.87M | 35.13M | 40.21M |
Total Equity | 5M | 363.58M | 314.92M | 265.35M |
Market Cap | 158.95M |
Price to Earnings Ratio | -2.36 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.74 |
Price to Book Ratio | 0.57 |
Dividend Yield | - |
Shares Outstanding | 126.15M |
Average Volume (1 week) | 138.36k |
Average Volume (1 Month) | 125.72k |
52 Week Change | -53.51% |
52 Week High | 3.09 |
52 Week Low | 1.10 |
Spread (Intraday) | 0.92 (45.1%) |
Company Name | Nautilus Biotechnology Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.nautilus.bio |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions